Article
Precision medicine for asthma treatment: Unlocking the potential of the epigenome and microbiome
19 Jun 2024
Abstract excerpt
Asthma is a leading worldwide biomedical concern. Patients can experience life-threatening worsening episodes (exacerbations) usually controlled by anti-inflammatory and bronchodilator drugs. However, substantial heterogeneity in treatment response exists, and a subset of patients with unresolved asthma carry the major burden of this disease. The study of the epigenome and microbiome might bridge the gap between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
